Cargando…
Interleukin-13 Signaling and Its Role in Asthma
Asthma affects nearly 300 million people worldwide. The majority respond to inhaled corticosteroid treatment with or without beta-adrenergic agonists. However, a subset of 5 to 10% with severe asthma do not respond optimally to these medications. Different phenotypes of asthma may explain why curren...
Autores principales: | Rael, Efren L, Lockey, Richard F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651056/ https://www.ncbi.nlm.nih.gov/pubmed/23283176 http://dx.doi.org/10.1097/WOX.0b013e31821188e0 |
Ejemplares similares
-
Oxymetazoline Hydrochloride Combined With Mometasone Nasal Spray for Persistent Nasal Congestion (Pilot Study)
por: Rael, Efren L, et al.
Publicado: (2011) -
The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
por: Marone, Giancarlo, et al.
Publicado: (2019) -
Th2 cytokines and asthma — Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists
por: Steinke, John W, et al.
Publicado: (2001) -
Aspirin-Exacerbated Asthma
por: Varghese, Mathew, et al.
Publicado: (2008) -
Interleukin-32: its role in asthma and potential as a therapeutic agent
por: Xin, Tong, et al.
Publicado: (2018)